Composition
- Active ingredients
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE · TabletNDA021698-002 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE · TabletNDA021698-001 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE · Tablet, effervescentThis page
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE/PACKET · Granule, effervescentNDA020251-002 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA018703-001 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020095-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020251.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Zantac 150
- Active substance
- ranitidine hydrochloride
- Route
- Oral
- Dosage form
- Tablet, effervescent
- Applicant
- Glaxo GRP LTD
- Status
- Discontinued
- FDA approval
- 31 Mar 1994
- Application
- NDA020251-001